Pharmaceutical Lyophilisation Summit

April 2017



Hotel Eurostars Berlin

Friedrichstraße 99, 10117

About Summit

This premier event provides the appropriate platform to discuss and network with peers involved in pharmaceutical manufacturing, R&D, quality control, engineering, and container development. The summit will shed light on practical considerations for freeze-dried formulation development, process optimization, validation and control for lyophilised biologics and vaccines.

Who Should Attend

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, Senior Managers, Scientists, Chemists, Engineers and Fellows specialising in:

  • Bioprocess
  • Container development
  • Drug development
  • Freeze-drying
  • Lyophilisation
  • Parenterals
  • Process technology and analytics
  • Packaging
  • Characterization
  • CMC
  • Engineering
  • Formulation
  • Nanomaterials
  • Packaging and labelling
  • Process monitoring and control
  • QA/QC
Key Practical Learning Points of the Summit

Manufacturing: critical issues and solutions
Process optimisation, monitoring and control
Innovations in formulation development
Model-based process engineering
QbD and PAT approaches
Strategies for scale-up from R&D scale to full production level
Technological solutions
Standards and validation
Regulatory considerations
Dr. Sune Klint Andersen, MBA

Principal Scientist, Spray Drying and Enabling Technologies

Janssen Research & Development, Belgium

Dr. Stefan Schneid

Laboratory Head Development Parenterals

Bayer Pharma, Germany

Dr. Sophie Declomesnil

R&D Manager


Dr. Jean René Authelin

Global Head of Pharmaceutical Engineering

Sanofi-Aventis, France

Richard Denk

Head Containment Group

Skan AG, Switzerland

Franz Bosshammer, MBA

Senior Specialist CD Execution/Experts

NNE Pharmaplan, Germany

Dr. Christoph Korpus

Laboratory Head – Liquid Formulation Stability

Merck KGaA, Germany

Sponsors and Partners



Media partner

Media partner

Media partner